CAS 1502829-45-9

Gefitinib Impurity 55

CAS: 1502829-45-9

Formel: C₂₉H₃₇ClFN₅O₄

Farbe und Form: White To Off-White Solid

Molekulargewicht: 574.09

Ref: 4Z-G-237

N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]-N-[3-(morpholin-4-yl)propyl]quinazolin-4-amine

CAS: 1502829-45-9

Farbe und Form: Neat

Ref: 86-MM3563.21

N-(3-Morpholinopropyl) Gefitinib

Kontrolliertes Produkt

CAS: 1502829-45-9

Applications N-(3-Morpholinopropyl) Gefitinib is a Gefitinib (G304000) impurity. It can also be synthesized from O-Desmorpholinopropyl Gefitinib (D296830).
References Anderson, N.G., et al.: Int. J. Cancer, 94, 774 (2001); Hirata, A., et al.: Cancer Res., 62, 2554 (2002); Kris, M.G., et al.: J. Am. Med. Assoc., 290, 2149 (2003); Tamura, K., et al.: Expert Opin. Pharmacother., 6, 985 (2005); Ranson, M., et al.: J. Clin. Oncology, 20, 2240 (2002); Mendelsohn, J., et al.: J. Clin. Oncology, 21, 2787 (2003); McKillop, D., et al.: Xenobiotica, 10, 917 (2004);

Formel: C₂₉H₃₇ClFN₅O₄

Farbe und Form: Neat

Molekulargewicht: 574.087

Ref: TR-M725210

N-(3-Morpholinopropyl) Gefitinib-D8

Kontrolliertes Produkt

CAS: 1502829-45-9

Applications N-(3-Morpholinopropyl) Gefitinib-D8 is a labelled Gefitinib (G304000) impurity.
References Anderson, N.G., et al.: Int. J. Cancer, 94, 774 (2001), Hirata, A., et al.: Cancer Res., 62, 2554 (2002), Kris, M.G., et al.: J. Am. Med. Assoc., 290, 2149 (2003), Tamura, K., et al.: Expert Opin. Pharmacother., 6, 985 (2005),

Formel: C₂₉D₈H₂₉ClFN₅O₄

Farbe und Form: Neat

Molekulargewicht: 582.136

Ref: TR-M725212

Gefitinib Impurity 55

CAS: 1502829-45-9

Formel: C₂₉H₃₇ClFN₅O₄

Molekulargewicht: 574.09

Ref: ST-EA-CP-G14046